Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis

Area of Science:

• Oncology
• Metabolism
• Immunology

Background:

• Food intake significantly impacts health and disease, with nutrients influencing metabolic equilibrium.
• Obesity is a major risk factor for cancer and metastasis, driven by systemic inflammation.
• Obesity-associated adipose tissue releases chemokines that promote cancer cell spread.

Purpose of the Study:

• To investigate the role of obesity-induced chemokines in cancer metastasis.
• To identify specific chemokines involved in the metastatic process.
• To explore the potential of anti-obesity and anti-inflammatory nutrients in cancer management.

Main Methods:

• Review of literature linking obesity, inflammation, chemokines, and cancer metastasis.
• Identification of key chemokines (e.g., CCL2, CXCL12) upregulated in obesity and associated with cancer.
• Analysis of nutrient constituents with anti-inflammatory and anti-obesity properties.

Main Results:

• Obesity promotes cancer metastasis via inflammation and elevated chemokine levels in adipose tissue.
• Specific chemokines (CCL2-12, CXCL1-12) are implicated in all stages of metastasis.
• Obesity is linked to increased risk and poorer outcomes in breast, prostate, colon, liver, and stomach cancers.
• Anti-inflammatory nutrients like polyphenols, curcumin, and vitamin E show promise in mitigating obesity-related metastasis.

Conclusions:

• Controlling obesity is crucial for reducing pro-inflammatory chemokines and lowering cancer metastasis risk.
• Dietary interventions with anti-obesity and anti-inflammatory nutrients may support cancer treatment and improve outcomes.
• Understanding the interplay between diet, obesity, and cancer metastasis is vital for prevention and therapy.